Pramlintide
A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects
AstraZeneca · Phase 2 · Terminated · Enrollment 213
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Group A | n/r | n/r | n/r | n/r | n/r |
| Group B | n/r | n/r | n/r | n/r | n/r |
| Placebo | 1 participants | n/r | n/r | n/r | n/r |
| Pramlintide + Metreleptin | 7 participants | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.